Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:Subscribe to Clinics in Laboratory Medicine
- Spirillosis of cattle.J Comp Pathol. 1904; 17: 47-55
- Genetic and phenotypic analysis of Borrelia miyamotoi sp. nov., isolated from the ixodid tick Ixodes persulcatus, the vector for Lyme disease in Japan.Int J Syst Bacteriol. 1995; 45: 804-810
- A new borrelia infecting lone star ticks.Lancet. 1996; 347: 67-68
- Identification of an uncultivable Borrelia species in the hard tick, amblyomma americanum.J Infect Dis. 1996; 173: 403-409
- Phylogeny of a relapsing fever Borrelia species transmitted by the hard tick Ixodes scapularis.Infect Genet Evol. 2014; 27: 551-558
- Observations on tick-transmitted spirochaetes of cattle in Australia and South Africa.Br Vet J. 1967; 123: 492-497
- Borrelia theileri: isolation from ticks (Boophilus microplus) and tick-borne transmission between splenectomized calves.Am J Vet Res. 1985; 46: 1396-1398
- Southern tick-associated rash illness (STARI) in the north: STARI following a tick bite in Long Island, New York.Clin Infect Dis. 2011; 53: e142-e146
- Humans infected with relapsing fever spirochete Borrelia miyamotoi, Russia.Emerg Infect Dis. 2011; 17: 1816-1823
- Meningoencephalitis from Borrelia miyamotoi in an immunocompromised patient.N Engl J Med. 2013; 368: 240-245
- A case of meningoencephalitis by the relapsing fever spirochete Borrelia miyamotoi in Europe.Lancet. 2013; 382: 658
- Borrelia miyamotoi disease in the northeastern United States: a case series.Ann Intern Med. 2015; 163: 91-98
- Borrelia miyamotoi sensu lato seroreactivity and seroprevalence in the northeastern United States.Emerg Infect Dis. 2014; 20: 1183-1190
- Taiga tick: Ixodes persulcatus schulze (acarina: ixodidae).Nauka Publishers, Leningrad (Russia)1985: 416
- Surveillance for Lyme disease—United States, 1992-2006.MMWR Surveill Summ. 2008; 57: 1-9
- A relapsing fever group spirochete transmitted by Ixodes scapularis ticks.Vector Borne Zoonotic Dis. 2001; 1: 21-34
- Relapsing fever-like spirochetes infecting European vector tick of Lyme disease agent.Emerg Infect Dis. 2003; 9: 697-701
- Detection of a Borrelia miyamotoi sensu lato relapsing-fever group spirochete from Ixodes pacificus in California.J Med Entomol. 2006; 43: 120-123
- Investigation of genotypes of Borrelia burgdorferi in Ixodes scapularis ticks collected during surveillance in Canada.Appl Environ Microbiol. 2011; 77: 3244-3254
- Niche partitioning of Borrelia burgdorferi and Borrelia miyamotoi in the same tick vector and mammalian reservoir species.Am J Trop Med Hyg. 2009; 81: 1120-1131
- Are Apodemus spp. mice and Myodes glareolus reservoirs for Borrelia miyamotoi, Candidatus Neoehrlichia mikurensis, Rickettsia helvetica, R. monacensis and Anaplasma phagocytophilum?.Ticks Tick Borne Dis. 2014; 5: 245-251
- Borrelia miyamotoi infections among wild rodents show age and month independence and correlation with Ixodes persulcatus larval attachment in Hokkaido, Japan.Vector Borne Zoonotic Dis. 2013; 13: 92-97
- Associations of passerine birds, rabbits, and ticks with Borrelia miyamotoi and Borrelia andersonii in Michigan, U.S.A.Parasit Vectors. 2012; 5: 231
- Transovarial transmission of Borrelia spirochetes by Ixodes scapularis: a summary of the literature and recent observations.Ticks Tick Borne Dis. 2013; 4: 46-51
- Transstadial and transovarial development of disease agents in arthropods.Annu Rev Entomol. 1967; 12: 347-376
- Rocky mountain spotted fever: infectivity of fasting and recently fed ticks.Publ Health Rep. 1923; 38: 333
- Duration of tick attachment required for transmission of human granulocytic ehrlichiosis.J Infect Dis. 1998; 177: 1422-1425
- The burgeoning molecular genetics of the Lyme disease spirochaete.Nat Rev Microbiol. 2005; 3: 129-143
- Blood transfusion transmission of the tick-borne relapsing fever spirochete Borrelia miyamotoi in mice.Transfusion. 2015; 55: 593-597
- Borrelia miyamotoi infection presenting as human granulocytic anaplasmosis: a case report.Ann Intern Med. 2013; 159: 21-27
- Relapsing fever. A clinical and microbiological review.Medicine. 1969; 48: 129-149
- Immunobiology of relapsing fever.Contrib Microbiol Immunol. 1987; 8: 125-127
- The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the infectious diseases society of America.Clin Infect Dis. 2006; 43: 1089-1134
- Recommendations for test performance from the second national conference on serologic diagnosis of Lyme disease.MMWR Surveill Summ. 1995; 44: 590-591
- GlpQ: an antigen for serological discrimination between relapsing fever and Lyme borreliosis.J Clin Microbiol. 1996; 34: 2483-2492
- The relapsing fever spirochete Borrelia miyamotoi is cultivable in a modified Kelly-Pettenkofer medium, and is resistant to human complement.Parasit Vectors. 2014; 7: 418
- Long-term in vitro cultivation of Borrelia miyamotoi.Ticks Tick Borne Dis. 2015; 6: 181-184
- Essential malariology.2nd edition. John Wiley and Sons, New York1985: 452
- Standardisation of a complex medium for the growth of Borrelia burgdorferi.J Clin Microbiol. 1993; 31: 1251-1255
- Emerging and emergent tick borne infections.in: Chappell L.H. Bowman A.S. Nuttall P.A. Ticks: biology, disease and control. Cambridge University Press, Cambridge, UK2008: 344-376
Potential Conflicts of Interest: V.P. Berardi is an associate director of laboratory science and CEO of Imugen, Inc. P.J. Molloy and H.K. Goethert are employees of Imugen, Inc. H.R. Chowdri is a clinical consultant and S.R. Telford is a consultant and scientific advisor to Imugen, Inc.
S.R. Telford and H.K. Goethert are supported, in part, by grants from the National Institutes of Health (U01AI109656, R41AI078631); the Tufts Innovation Institute; the Evelyn Lilly Lutz Foundation; the Dorothy Harrison Egan Foundation; and the Bill and Melinda Gates Foundation.